FindMyRecallSubscribe
Class III: unlikely to cause harmOngoing

Zydus Pharmaceuticals (USA) traZODONE Hydrochloride Tablets Recall

traZODONE Hydrochloride Tablets, USP, 100mg, 1,000 Tablets, Rx only, Manufactured by: Z…

Zydus Pharmaceuticals (USA) Inc · Pennington, NJ

Risk level
Class III
Reported by FDA
Jan 7, 2026
Recall ID
D-0247-2026
Check your lot numberHow we source this data

Summary

Zydus Pharmaceuticals (USA) recalled traZODONE Hydrochloride Tablets starting Dec 19, 2025. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0247-2026 on Jan 7, 2026. Reason: Failed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface. Status: Ongoing.

Why it was recalled

Failed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface.

Product description

traZODONE Hydrochloride Tablets, USP, 100mg, 1,000 Tablets, Rx only, Manufactured by: Zydus Lifesciences Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-806-10

Lot numbers, UPCs & expiration codes

Lot # EA00237A, Exp Date: 04/30/2027

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0247-2026
Classification
Class III
Status
Ongoing
Recall initiated
Dec 19, 2025
FDA report date
Jan 7, 2026
Quantity
2,136 1000-count bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Zydus Pharmaceuticals (USA) Inc

Original FDA data

Every field from FDA enforcement report D-0247-2026, exactly as published.

Show all FDA fields
City
Pennington
State
NJ
Status
Ongoing
Country
United States
Event ID
98184
Address
73 Route 31 N
Code information
Lot # EA00237A, Exp Date: 04/30/2027
Postal code
08534-3601
Report date
Jan 7, 2026
Product type
Drugs
Recall number
D-0247-2026
Classification
Class III
Recalling firm
Zydus Pharmaceuticals (USA) Inc
Product quantity
2,136 1000-count bottles
Reason for recall
Failed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface.
Voluntary / mandated
Voluntary: Firm initiated
Product description
traZODONE Hydrochloride Tablets, USP, 100mg, 1,000 Tablets, Rx only, Manufactured by: Zydus Lifesciences Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-806-10
Distribution pattern
Nationwide in the USA
Recall initiation date
Dec 19, 2025
Initial firm notification
Letter
Center classification date
Dec 31, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0247-2026, published Jan 7, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls